Sunday, January 17, 2021

Latest Coronavirus News

Govt preparing a plan to boost pharma R&D

A govt-appointed committee will frame policy for firms to conduct research in India for drug discovery.  Now that the...

Five sites in India ready for Oxford-AstraZeneca COVID-19 vaccine trial: DBT

Renu Swarup, Secretary, Department of Biotechnology (DBT) told PTI that five sites across the country are ready for the third and final...

Covid-19 vaccine will be ready by year end in ‘best case scenario’: Pfizer

 Pfizer, which has struck a nearly $2 billion deal with the US government to deliver 100 million doses of a Covid-19 vaccine developed in...

Jenburkt Pharmaceuticals second in India to launch Favipiravir (FaviventTM) to fight COVID-19

Jenburkt Pharmaceuticals announced the launch of antiviral drug Favipiravir (brand name Favivent™) for the treatment of mild to moderate COVID-19 symptoms at...

Cipla all set to launch Favipiravir drug for treatment of COVID patients: CSIR

Pharmaceutical firm Cipla is all set to launch Favipiravir, developed by the Council of Scientific and Industrial Research (CSIR) in a cost-effective process, for...

Seven Indian pharmaceutical companies race to develop vaccine for deadly coronavirus

At least seven Indian pharma companies are working to develop a vaccine against coronavirus as they join global efforts to find a preventive...
- Advertisement -
Advertisment